Edwin H. Kim CV
Edwin, H., Kim, CV
FDA/CDER GCRC
Kim Edwin Unredacted CV 09-11-2019 PADAC Edwin H. Kim
3004C Mary Ellen Jones Bldg 116 Manning Dr, CB 8035 Chapel Hill, NC 27599 edwinkim@email.unc.edu
Education
7/2008 6/2011
Duke University School of Medicine, Durham, NC Fellowship: Allergy & Immunology
7/2005 6/2008
Duke University School of Medicine, Durham, NC Residency: Pediatrics
8/2001 6/2005
UMDNJ-Robert Wood Johnson Medical School, Piscataway Township, NJ MD
8/1999 6/2001
Harvard School of Public Health, Boston, MA MS, Health Policy & Management
8/1992 6/1996
Massachusetts Institute of Technology, Boston, MA BS, Biology
Professional Experience Employment History
7/2017 present
Medical Director
University of North Carolina Allergy and Immunology Clinic, Chapel Hill, NC
10/2015 present
Director University of North Carolina Food Allergy Initiative Research Group, Chapel Hill, NC
9/2015 present
Program Director University of North Carolina Allergy and Immunology Fellowship Training Program, Chapel Hill, NC
7/2014 8/2015
Associate Program Director University of North Carolina Allergy and Immunology Fellowship Training Program, Chapel Hill, NC
9/2013 present
Assistant Professor University of North Carolina School of Medicine, Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill, NC
9/2011 present
Assistant Professor University of North Carolina School of Medicine, Department of Medicine, Division of Rheumatology, Allergy & Immunology, Chapel Hill, NC
11/2000 6/2001
Intern The Women's Care Network, Boston, MA e-health marketplace analysis for development of a web-based physician/patient interface
6/2000 8/2000
Intern Institute for Medical Quality, San Francisco, CA Assessment of California's third-party external review program for denials of medical reimbursement
10/1997 1/1999
Research Technician Dana Farber Cancer Institute, Boston, MA Development of a non-radioactive screen for mutations in the BRCA genes using heteroduplex PCR
6/1995 5/1997
Research Technician MIT Department of Biology, Boston, MA Investigation of the early development of the immune system in zebrafish
Certifications/ Licensure
2011 present
American Board of Allergy and Immunology
2010 2015
American Board of Pediatrics
2009 present
North Carolina Medical Board Full License #2008-00846
Honors and Awards
Teaching 2006 2007 2005 2006
Intensive Care Nursery Outstanding Junior Resident Award, Duke Medical Center Exceptional Dedication to Medical Student Training Award, Duke Medical Center
Clinical 2011 present 2005 2011
"High 5" (3 written patient commendations), Patient Relations, UNC Health Care "Service Champion" (8 written patient commendations), Patient-Visitor Relations, Duke Medical Center
Bibliography and Products of Scholarship
Refereed Papers/Articles EH Kim, LYang, P Ye, R Guo, Q Li, MD Kulis, AW Burks. Long-Term Sublingual Immunotherapy for Peanut Allergy in Children: Clinical and Immunologic Evidence of Desensitization. J Allergy Clin Immunol. 2019, doi: 10.1016/j.jaci.2019.07.030.
BC Remington, T Krone, EH Kim, JA Bird, TD Green, G Lack, DM Fleischer, SJ Koppelman. Estimated Risk Reduction to Packaged Food Reactions by Epicutaneous Immunotherapy (EPIT) for Peanut Allergy. Ann Allergy Asthma Immunol. 2019, doi: 10.1016/j.anai.2019.08.007.
DM Fleischer, M Greenhawt, G Sussman, P Bégin, A Nowak-Wegrzyn, D Petroni, K Beyer, T BrownWhitehorn, J Hebert, JO Hourihane, DE Campbell, S Leonard, RS Chinthrajah, JA Pongracic, SM Jones, L Lange, H Chong, TD Green, R Wood, A Cheema, SL Prescott, P Smith, W Yang, ES Chan, A Byrne, A Assa'ad, JA Bird, EH Kim, L Schneider, CM Davis, BJ Lanser, R Lambert, W Shreffler. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 Feb 22. doi: 10.1001/jama.2019.1113.
Q Cook, E Kim. Update on Peanut Allergy: Prevention and Immunotherapy. Allergy Asthma Proc. 2019 Jan 1;40(1):14-20. doi: 10.2500/aap.2019.40.4190.
P Gamage, C McMahan; M Chaudhari, E Kim, M Kosorok. A proportional hazards model for intervalcensored data subject to instantaneous failures. Lifetime Data Anal. 2019 Feb 23. doi: 10.1007/s10985019-09467-z.
BP Vickery, A Vereda, TB Casale, K Beyer, G du Toit, JO Hourihane, SM Jones, WG Shreffler, A Marcantonio, R Zawadzki, L Sher, WW Carr, S Fineman, L Greos, R Rachid, MD Ibáñez, S Tilles, AH Assa'ad, C Nilsson, N Rupp, MJ Welch, G Sussman, S Chinthrajah, K Blumchen, E Sher, JM Spergel, FE Leickly, S Zielen, J Wang, GM Sanders, RA Wood, A Cheema, C Bindslev-Jensen, S Leonard, R Kachru, DT Johnston, FC Hampel, EH Kim, A Anagnostou, JA Pongracic, M Ben-Shoshan, HP Sharma, A Stillerman, HH Windom, WH Yang, A Muraro, JM Zubeldia, V Sharma, MJ Dorsey, HJ Chong, J Ohayon, JA Bird, TF Carr, D Siri, M Fernández-Rivas, DK Jeong, DM Fleischer, JA Lieberman, AEJ Dubois, M Tsoumani, CE Ciaccio, JM Portnoy, LE Mansfield, SB Fritz, BJ Lanser, J Matz, HNG Oude Elberink, P Varshney, SG Dilly, DC Adelman, AW Burks. AR101 Oral Immunotherapy for Peanut Allergy. N Eng J Med. 2018; 379:19912001. doi: 10.1056/NEJMoa1812856.
M Kulis, X Yue, R Guo, H Zhang, K Orgel, P Ye, Q Li, Y Liu, E Kim, A Burks, B Vickery. High and Low Dose Oral Immunotherapy Similarly Suppress Pro-Allergic Cytokines and Basophil Activation in Young Children. Clin Exp Allergy. 2018; doi: 10.1111/cea.13256
M Chaudhari, EH Kim, PW Gamage, CS McMahan, MR Kosorok. Study Design with Staggered Sampling Times for Evaluating Sustained Unresponsiveness to Peanut Sublingual Immunotherapy. Stat Med. 2018; 37:39443958.
WG Shreffler, JL Baumert, BC Remington, SJ Koppelman, C Dinakar, DM Fleischer, E Kim, SA Tilles, JM Spergel. The importance of reducing risk in peanut allergy: Current and future therapies. Ann Allergy Asthma Immunol. 2018; 120:124127.
JA Bird, J Spergel, S Jones, R Rachid, A Assa'ad, J Wang, SA Leonard, S Laubach, EH Kim, BP Vickery, BP Davis, J Heimall, A Cianferoni, AJ MacGinnitie, E Crestani, W Burks. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled Phase-2 clinical trial. J Allergy Clin Immunol In Pract. 2018; 6:476-485.
HX Chen, R Blasiak, E Kim, R Padilla, DA Culton. Triggers of oral lichen planus flares and the potential role of trigger avoidance in disease management. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 124:248-252.
BP Vickery, JP Berglund, CM Burk, JP Fine, EH Kim, JI Kim, CA Keet, M Kulis, KG Orgel, R Guo, PH Steele, YV Virkud, P Ye, BL Wright, RA Wood, AW Burks. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017; 139(1):173-181.
A Hamad, EH Kim. Early Introduction of Allergenic Foods is Safe and May Be Beneficial. J Allergy Clin Immunol In Pract. 2016; 5(2):531-532.
C Burk, M Kulis, N Leung, EH Kim, AW Burks, BP Vickery. Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy. Clin Exp Allergy. 2016; 46(2): 347-353.
SJ Chin, BP Vickery, MD Kulis, EH Kim, P Varshney, P Steele, J Kamilaris, AM Hiegel, SK Carlisle, PB Smith, AM Scurlock, SM Jones, AW Burks. Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison. J Allergy Clin Immunol. 2013; 132(2): 476-478.
MD Kulis, K Saba, EH Kim, JA Bird, N Kamilaris, BP Vickery, H Staats, AW Burks. Increased peanutspecific IgA in saliva correlates with food challenge outcomes following peanut sublingual immunotherapy. J Allergy Clin Immunol. 2012; 129(4):1159-1162.
EH Kim, JA Bird, MD Kulis, S Laubach, L Pons, WG Shreffler, PH Steele, J Kamilaris, BP Vickery, AW Burks. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011; 127(3):640-646.
TD Green, VS LaBelle, PH Steele, EH Kim, LA Lee, VS Mankad, LW Williams, KJ Anstrom, AW Burks. Clinical characteristics of peanut-allergic children: recent changes. Pediatrics. 2007; 120(6): 1304-1310.
N Danilova, VS Hohman, EH Kim, LA Steiner. Immunoglobulin variable-region diversity in the zebrafish. Immunogenetics. 2000; 52: 81-91.
Published Abstracts EH Kim, SM Jones, AW Burks, RA Wood, SH Sicherer, DYM Leung, AK Henning, RW Lindblad, P Dawson, C Keet, AM Scurlock, HA Sampson. A 5-year Summary of Real-life Dietary Egg Consumption after Completion of a 4-year Egg OIT Protocol. J Allergy Clin Immunol 2019; 143(2) Supp: AB82. (oral abstract presenter)
W Carr, BP Vickery, R Zawadzki, NM Griffin, DC Adelman, A Ratnayake, EH Kim. Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, PlaceboControlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101. J Allergy Clin Immunol 2019; 143(2) Supp: AB262. (poster presenter)
Q Cook, L Yang, A Hamad, H Barber, L Herlihy, AW Burks, EH Kim Dosing and Safety of Peanut Food Equivalents After Immunotherapy Trials. J Allergy Clin Immunol 2019; 143(2) Supp: AB244. (poster)
L Yang, Q Cook, A Hamad, H Barber, L Herlihy, AW Burks, EH Kim. Back to Life, Back to Reality What Happens after Peanut Immunotherapy? A Long-Term Follow up Study on Perceptions of Safety and Lifestyle. J Allergy Clin Immunol 2019; 143(2) Supp: AB246. (poster)
L Herlihy, EH Kim, A Hamad, Q Cook, DK Hamilton, H Barber, AW Burks, BP Vickery. Five Year Follow-Up Of Early Intervention Peanut OIT Showed Characteristics of Sustained and Prolonged Clinical Benefit. J Allergy Clin Immunol 2019; 143(2) Supp: AB264. (poster)
A Penumarti, N Szczepanski, J Kesselring, E Gabel, R Sheth, JP Berglund, EH Kim, AW Burks, MD Kulis. Irradiated Almond Flour Meets Established Criteria for use in Oral Immunotherapy. J Allergy Clin Immunol 2019; 143(2) Supp: AB244. (poster)
M Chaudhari, E Kim. Study Design with Staggered Sampling Times for Evaluating Sustained Unresponsiveness to Peanut Sublingual Immunotherapy. J Allergy Clin Immunol 2018; 141(2) Supp: AB88. (oral abstract)
A Hamad, E Kim. A novel assessment of sustained unresponsiveness (SU) after long term sublingual immunotherapy (SLIT) in peanut allergic children: results of a 4 year phase II clinical trial. J Allergy Clin Immunol 2018; 141(2) Supp: AB200. (featured poster)
A Penumarti, E Kim. Impact of Irradiation on the Protein Content and Microbial Levels of Sesame Seed Flour for use in Oral Immunotherapy. J Allergy Clin Immunol 2018; 141(2) Supp: AB241. (poster)
D Hamilton, E Kim. Assessing the validity of an IRB approved REDCap web based clinical trials recruitment registry. J Allergy Clin Immunol 2018; 141(2) Supp: AB257. (poster)
M Kulis, E Kim. A mouse model of walnut allergy mimics key features of the human disease. J Allergy Clin Immunol 2018; 141(2) Supp: AB248. (poster)
Q Cook, E Kim. Characteristics of Preschool-Aged Children Currently Enrolled in a Phase II Double Blind Placebo Controlled Study of Peanut Sublingual Immunotherapy. J Allergy Clin Immunol 2018; 141 Supp: AB263. (poster)
L Yang, PH Steele, D Hamilton, S Bennick, L Herlihy, E Pitkin, AW Burks, EH Kim. Sustained Unresponsiveness After Sublingual Immunotherapy for Peanut-allergic Children. J Allergy Clin Immunol. 2017; 139(2) Supp: AB175. (oral abstract)
X Yue, M Kulis, H Zhang, R Guo, K Orgel, E Kim, AW Burks, BP Vickery. Low and High Dose Peanut OIT Similarly Suppress Th2 Cytokine and Basophil Activation Responses. J Allergy Clin Immunol. 2017; 139(2) Supp: AB562. (oral abstract, presenter)
A Penumarti, N Szczepanski, J Kesselring, E Gabel, E Kim, AW Burks, M Kulis. Impact of Microwaving on the Protein Content and Microbial Levels of Whole Wheat Flour for Use in Oral Immunotherapy. J Allergy Clin Immunol. 2017; 139(2) Supp: AB866. (oral abstract, presenter)
A Hamad, D Hamilton, P Steele, S Bennick, L Herlihy, E Pitkin, E Kim, AW Burks. Sublingual Peanut Immunotherapy: Role of duration and dose. J Allergy Clin Immunol. 2017; 139(2) Supp: AB61. (poster)
L Herlihy, S Bennick, D Hamilton, E Pitkin, E Kim. Controlled Asthma Not Correlated with Respiratory Symptoms During DBPCFCs (Double Blind Placebo Controlled Food Challenges) to Peanut in Children. J Allergy Clin Immunol. 2017; 139(2) Supp: AB420. (poster)
M Kulis, C Burk, X Yue, H Zhang, R Guo, K Orgel, P Ye, BP Vickery, E Kim, AW Burks. Six month course of peanut OIT leads to suppression of basophil activation which begins to wane within four weeks after OIT is stopped. J Allergy Clin Immunol. 2017; 139(2) Supp: AB430. (poster)
EH Kim, BP Vickery, A Radwan, AW Burks. Immunologic Effects of AR101 During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy. Ann Allergy Asthma Immunol. 2016; 117(5) Supp: O055. (oral abstract, presenter)
A Fatima, EH Kim. Eosinophilic Gastroenteritis in a Study of Sublingual Immunotherapy (SLIT) for Peanut Allergy. Ann Allergy Asthma Immunol. 2016; 117(5) Supp: P272. (poster)
P Ye, MD Kulis, RGuo, EH Kim, BP Vickery, AW Burks. Sublingual Immunotherapy (SLIT) Regulates the Expression of Transcription Factors and Interleukins in Peanut Allergic Children. J Allergy Clin Immunol. 2016; 137(2) Supp: AB194. (featured poster)
ME Breslin, DK Hamilton, R Guo, P Ye, X Jiang, P Stewart, S Chin, EH Kim, AW Burks. Basophil Activation and Peanut-Specific IgE Are Not Predictors of Threshold Dose during a Double-Blind Placebo-Controlled Food Challenge (DBPCFC). J Allergy Clin Immunol. 2016; 137(2) Supp: AB125. (poster)
JA Bird, JM Spergel, SM Jones, R Rachid, AH Assa'ad, J Wang, SA Leonard, SS Laubach, EH Kim, BP Vickery, B Davis, J Heimall, A Cianferoni, AJ MacGinnitie, E Crestani, RM Elfont, HA Sampson, AW Burks. A novel characterized peanut allergen formulation (AR101) for oral immunotherapy (OIT) induces
desensitization in peanut-allergic subjects: a Phase 2 clinical safety and efficacy study. Allergy, 2015; 70:110. (oral abstract)
EH Kim, PH Steele, MD Kulis, A Beavers, DK Hamilton, R Guo, BP Vickery, AW Burks. Peanut sublingual immunotherapy (SLIT) results in sustained unresponsiveness in a subset of peanut allergic children. J Allergy Clin Immunol. 2015; 135(2) Supp: AB155. (oral abstract)
EH Kim, SJ Chin, P Steele, J Kamilaris, N Kamilaris, C Burk, M Kulis, BP Vickery, AW Burks. Tolerance induction in an interim analysis of peanut sublingual immunotherapy. J Allergy Clin Immunol. 2013; 131(2) Supp: AB130. (oral abstract, presenter)
EH Kim, MD Kulis, BP Vickery, AW Burks. Induction of regulatory T cells after peanut sublingual immunotherapy. J Allergy Clin Immunol. 2012; 129(2) Supp: AB27. (poster, presenter)
EH Kim, JA Bird, MD Kulis, S Laubach, L Pons, WG Shreffler, PH Steele, J Kamilaris, BP Vickery, AW Burks. Evidence of Desensitization in a Study of Sublingual Immunotherapy for Peanut Allergy. Clin Exp Allergy. 2011; 41:1823. (oral abstract, presenter)
EH Kim, JA Bird, MD Kulis, S Laubach, L Pons, WG Shreffler, PH Steele, J Kamilaris, BP Vickery, AW Burks. Evidence of Desensitization by Sublingual Immunotherapy in Peanut-Allergic Children. J Allergy Clin Immunol. 2011; 127(2) Supp: AB72. (oral abstract, presenter)
EH Kim, JA Bird, PH Steele, J Kamilaris, AH Edie, BP Vickery, AW Burks. Safety of peanut sublingual immunotherapy (SLIT) in children with peanut allergy. J Allergy Clin Immunol. 2010; 125(2) Supp: AB20. (poster, presenter)
Unrefereed Publications CP Parrish, EH Kim, JA Bird. Interventional Therapies for the Treatment of Food Allergy. Immunol Allergy Clin N Am. 2018; 38(1):77-88.
EH Kim, AW Burks. Chapter 18: Food Allergies. Patterson's Allergic Diseases 8th edition. L. Grammer & P Greenberger (editors). 2018;
S Commins, EH Kim, K Orgel, M Kulis. Peanut Allergy: New Developments and Clinical Implications. Curr Allergy Asthma Rep. 2016; 16:35.
EH Kim, AW Burks. Immunological basis of food allergy (IgE-mediated, Non-IgE-mediated, and tolerance. Chemical Immunology and Allergy. RA Wood (editors). 2015; 101:8-16.
EH Kim. Food Challenge. Encyclopedia of Medical Immunology Allergic Diseases. IR Mackay, NR Rose (editors). 2014.
EH Kim, AW Burks. Oral and sublingual immunotherapy. Current Treatment Options in Allergy. M Worm, L Cox (editors). 2013; doi:10.1007/s40521-013-0004-7.
EH Kim, W Burks. Managing food allergy in childhood. Curr Opin Pediatr. 2012; 24:615-20. M Land, EH Kim, AW Burks. Oral desensitization for food hypersensitivity. Immunol Allergy Clin N Am. 2011; 31: 267-276.
R Firszt, EH Kim, L McWilliams, E Wu, SR Boden, S Chin. The role of pharmacogenomics in improving the management of asthma CME exam. J Allergy Clin Immunol. 2010; 125: 303-304.
Grand Rounds Presentations
3/21/2019
Immunotherapy for the treatment of Peanut Allergy. UNC Department of Pathology
Grand Rounds. Chapel Hill, NC.
3/20/2019
Immunotherapy for Food Allergy. UNC Otolaryngology Grand Rounds. Chapel Hill, NC.
1/10/2019
Emerging Therapies for Peanut Allergy. New Jersey Medical School Allergy & Immunology Grand Rounds. Newark, NJ.
10/17/2018
Basics of Food allergy. NC AHEC New Hanover Medical Center Internal Medicine Grand Rounds. Wilmington, NC.
3/22/2018
Drug Allergies Affecting the Care of Inpatients. UNC Department of Medicine Grand Rounds. Chapel Hill, NC.
8/31/2017
General Pediatrician as Food Allergist? Review of the LEAP study for Peanut Allergy. UNC Department of Pediatrics Grand Rounds. Chapel Hill, NC.
4/15/2016
Learning Early About Peanut Allergy (LEAP). UNC Rheumatology, Allergy and Immunology Grand Rounds. Chapel Hill, NC.
10/15/2015
Food immunotherapy: Where are we now? Achoo! What's New? Pediatric Allergy Update Conference. Children's Hospital of the King's Daughters. Norfolk VA.
12/17/2014
Nut-free, gluten-free, red meat-free living? Making sense of food allergies. NC AHEC New Hanover Medical Center Internal Medicine Grand Rounds. Wilmington, NC.
5/21/2013
Advances in the diagnosis and treatment of chronic urticaria. NC AHEC, Carolinas Medical Center Internal Medicine Grand Rounds. Charlotte, NC.
8/31/2012
Chronic urticaria and angioedema. UNC Rheumatology, Allergy and Immunology Grand Rounds. Chapel Hill, NC.
4/29/2011
Invited Lectures 4/5/2019
Evidence of Desensitization in a Study of Sublingual Immunotherapy for Peanut Allergy. UNC Rheumatology, Allergy and Immunology Grand Rounds, Chapel Hill, NC.
Immunotherapy for Food Allergy. UNC Medical Alumni Council spring meeting. Chapel Hill, NC.
3/20/2019
Immunotherapy for Peanut Allergy: Retraining the Allergic Immune System. Durham Technical Community College Spring 2019 Science Seminar Series. Durham, NC.
2/25/2019
SLIT: Efficacy and Patient Selection. 2019 AAAAI annual scientific meeting. San Francisco, CA.
2/23/2019
Tips and Tricks on Teaching a New Generation of Learner. 2019 AAAAI annual scientific meeting. San Francisco, CA.
11/18/2018
The Pros and Cons of EPIT for Peanut. 2018 ACAAI annual scientific meeting. Seattle, WA.
11/3/2018
Food Allergy 101. FARECon featuring Teen Summit 2018. Arlington, VA.
10/26/2018 9/28/2018 6/23/2018 3/11/2018 3/10/2018
3/2/2018 1/24/2018 1/19/2018 10/1/2017 9/15/2017 9/12/2017 8/22/2017 6/1/2017 6/1/2017 2/16/2017 2/5/2017 12/1/2016 8/17/2016
Update on Food Allergy Research. 2018 Children's Mercy Kansas City/ACAAI Conferences On-Line Allergy (COLA) conference series.
Overview and Update on Immunotherapy for Food Allergy. New Jersey Allergy, Asthma and Immunology Society annual meeting. Oyster Bay, NJ.
Overview and Update on Immunotherapy for Food Allergy. Louisiana Society of Allergy, Asthma & Immunology annual meeting. New Orleans, LA.
The Food Allergy Epidemic: Current Landscape and Future Directions. 2018 UNC KenanFlagler Business School Wellness Day Keynote Lecture. Chapel Hill, NC.
How clinicians and researchers are collaborating at UNC to develop treatments for debilitating food allergies. 2018 UNC Translational Medicine Symposium. Chapel Hill, NC.
Food Allergy. 2018 AAAAI Chrysalis Project Program. Orlando, FL.
Penicillin Allergy. UNC Pediatrics Noon Conference. Chapel Hill, NC.
Basics of Food Allergy. UNC Pediatrics Noon Conference. Chapel Hill, NC.
Overview and Update on Immunotherapy for Food Allergy. Illinois Society of Allergy, Asthma and Immunology annual meeting. Chicago, IL.
Update on Food Allergy Research. 2017 Children's Mercy Kansas City/ACAAI Conferences On-Line Allergy (COLA) conference series.
Innovative Approaches to Food Desensitization. 2017 Current Views in Allergy, Asthma and Immunology (Vol 45) program. Augusta University.
Update on Local Anesthetic Allergy. Division of obstetric anesthesia faculty meeting. Chapel Hill, NC.
Food Allergy Update. 2017 Eastern Allergy Conference. Palm Beach, FL.
Pro/Con Debate: Is oral peanut desensitization ready for mainstream use in clinical practice? 2017 Eastern Allergy Conference. Palm Beach, FL.
Updates on the Diagnosis and Treatment of Food Allergy. Duke Diet and Fitness Center guest lecture series. Durham, NC.
Overview of Angioedema. UNC Internal Medicine noon conference. Chapel Hill, NC.
Historical overview of immunotherapy and the emerging treatment landscape in peanut allergy. Aimmune Investor Research Symposium. New York, NY.
Immunotherapy for the treatment of food allergy. UNC Gillings Department of Nutrition Continuing Education Webinar Series. Chapel Hill, NC.
8/17/2016
Pitfalls and pearls in the diagnosis of food allergy. UNC Gillings Department of Nutrition Continuing Education Webinar Series. Chapel Hill, NC.
6/16/2015
Overview of drug allergy. UNC Internal Medicine noon conference. Chapel Hill, NC.
3/18/2015
Update on angioedema. Charlotte AHEC and UNC SOM 39th annual Internal Medicine Conference, Chapel Hill, NC.
3/25/2014
Food allergy: diagnostic and therapeutic challenges. UNC Eschelman School of Pharmacy Noon Lecture Series. Chapel Hill, NC.
3/21/2014
Reactions to food: Sorting out allergy from the rest. Charlotte AHEC and UNC SOM 38th annual Internal Medicine Conference, Chapel Hill, NC.
1/22/2014
Alternative forms of immunotherapy. Duke Allergy and Immunology Wednesday Seminar Series. Durham, NC.
2/22/2013
Difficult Cases: Oral Food Challenges. 2013 AAAAI Annual Scientific Meeting. San Antonio, TX.
4/4/2012
Chronic urticaria and angioedema. Duke Allergy and Immunology Wednesday Seminar Series, Durham, NC.
3/14/2012
Urticaria and angioedema for the internist. Charlotte AHEC and UNC SOM 36th annual Internal Medicine Conference, Chapel Hill, NC.
Professional Service
Memberships/Committees
2/2019 present
Executive committee: pediatric counselor, AAAAI Program Directors Assembly
3/2018 present
Member, World Allergy Organization (WAO) WinAIT committee
5/2017 present
Member, AAAAI Core Curriculum Committee
4/2016 present
Member, AAAAI CME/MOC Committee
3/2014 4/2016
Member, AAAAI Needs Assessment and Outcomes Committee
9/2012 present
Member, AAAAI Food allergy, Anaphylaxis, Dermatology and Drug allergy Interest
Group
7/2011 present
Fellow of American Academy of Allergy, Asthma, and Immunology (AAAAI)
7/2011 present
Fellow of American College of Allergy, Asthma, and Immunology (ACAAI)
Manuscript Reviews 04/2019 present 10/2013 present
Journal of Allergy and Clinical Immunology Journal of Allergy and Clinical Immunology In Practice
Service to University 4/2018 present 6/2016 present 6/2015 12/2015
9/2014 2/2015 3/2014 4/2014 1/2014 present
8/2013 4/2014
Department of Medicine Outpatient Leaders Group Physician Champion UNC Grateful Patient Program Member, Carolina Value School of Medicine Technology Transfer Implementation Team Member, Academy of Educators School of Medicine EPIC Utilization Committee Superuser, Epic@UNC Project Member, Thurston Arthritis Research Center and Division of Rheumatology, Allergy & Immunology 5-year Strategic Plan Education Committee Subject Matter Expert, Adult and Pediatric Allergy, Epic@UNC Project
7/2013 2/2014 7/2013 2/2014
Member, UNC Streamlining the Referral Process Task Force Member, UNC Provider Review of Referrals Task Force
FDA/CDER Adobe PDF Library 11.0